title: Fluorometholone-induced cataract after photorefractive keratectomy.
abstract: The use of topical corticosteroids following photorefractive keratectomy (PRK) is widespread. The major complications of potent corticosteroids are glaucoma and cataract formation; in order to decrease these complications, 0.1% fluorometholone administration is usually preferred after PRK. We report here a case of lens opacification which was induced by 0.1% fluorometholone administration after PRK in a period of 4 months. To our knowledge, this is the first reported case of 0.1% fluorometholone-induced cataract after PRK.
authors.affiliation: Department of Ophthalmology, University of Gazi, Ankara, Turkey.
authors.forename: K
authors.initials: K
authors.lastname: Bilgihan
authors.forename: G
authors.initials: G
authors.lastname: Gürelik
authors.forename: F
authors.initials: F
authors.lastname: Akata
authors.forename: B
authors.initials: B
authors.lastname: Hasanreisoglu
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001251:Astigmatism / Q000601:surgery; D002386:Cataract / Q000139:chemically induced* / Q000473:pathology; D003315:Cornea / Q000601:surgery*; D005260:Female; D005469:Fluorometholone / Q000008:administration & dosage / Q000009:adverse effects*; D005500:Follow-Up Studies; D005938:Glucocorticoids; D006801:Humans; D054018:Lasers, Excimer; D007908:Lens, Crystalline / Q000187:drug effects* / Q000473:pathology; D009883:Ophthalmic Solutions; D018903:Photorefractive Keratectomy
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D005469:Fluorometholone